Supply expansion as a driver of the opioid epidemic

Supply expansion as a driver of the opioid epidemic is the book’s account of how wider access to prescription opioids helped make addiction a national, rather than predominantly urban, problem. Its central claim is that economic hardship and personal vulnerability mattered, but neither explains the crisis on its own: the expansion of opioid supply came first, and illicit markets and uneven access to care extended its consequences.

The shift from an urban market

In the early 1990s, heroin remained concentrated in large cities such as New York City, Chicago, and Detroit. The widespread prescribing of OxyContin for noncancer pain in the late 1990s changed that geography. Once a newly approved prescription could bring opioids into ordinary medical settings, doctors in small towns could prescribe them to patients with conditions such as lower-back problems. The illicit opioid market was no longer the only route into opioid exposure, nor was opioid use confined to big-city settings.

The book makes supply expansion a primary cause, not a secondary response to economic decline. One historian’s assessment is that the increased supply through OxyContin preceded the other factors and that, without it, the epidemic would not have occurred in the same way. Economic depression and loss of morale could intensify the conditions in which addiction took hold, but the growing availability of opioids transformed the scale and reach of the risk.

How prescription supply was built

Purdue Pharma pursued rural, small-town markets where factories had closed, disability claims were rising, and many physicians were already prescribing competing painkillers. Using information purchased from IMS Health, the company identified doctors whose prescribing patterns made them likely targets for sales visits. Representatives emphasized OxyContin’s potency and longer-lasting action, and the doctors judged most promising received more frequent attention. Branded clocks and other office reminders helped make the product a steady presence in medical settings.

The effort went beyond selecting individual prescribers. Purdue Pharma’s sales force was expected to make more than a million annual calls to doctors in hospitals and offices, including family physicians, and to promote OxyContin for noncancer pain such as back pain, osteoarthritis, and injuries. Representatives traveled through rural Virginia towns including Big Stone Gap, Lebanon, and St. Charles. Some earned annual bonuses of $70,000, with larger bonuses tied to the milligram strength doctors prescribed. By 2000, family doctors had become the largest single group of OxyContin prescribers, a major shift from five years earlier, when cancer doctors had led in prescribing long-acting opioids.

That sales strategy took place amid a broader expansion in pharmaceutical promotion. After rules on television advertising for prescription drugs were loosened, drug advertising rose from $360 million in 1995 to $1.3 billion in 1998. The book presents this atmosphere of pill-based solutions and intensified promotion as part of the setting in which OxyContin marketing could encourage prescribing and patient demand.

Dependence, resale, and the illicit market

As prescription pills became expensive or difficult to obtain, established patterns of addiction made a transition to illegal supply foreseeable. The fear of running out and experiencing withdrawal created a market for dealers willing to meet continuing demand. The book compares this dynamic with earlier periods in which illegal sellers filled demand after heroin became prohibited: restricting one source did not automatically remove the need that dependence had created.

The cycle could also reproduce itself through users’ own transactions. In Woodstock, Virginia, some people began with prescriptions, then bought heroin and sold portions of what they had acquired to finance the next purchase. People who recruited customers could draw in further sellers and users, allowing the network to grow beyond its original participants. The consequence was not merely a change in drug source: a market first expanded through prescribing could persist through illicit sales, with the cycle ending in prison or premature death for some of those caught within it.

A separate supply chain in Roanoke illustrates how dealers could extend heroin into new social settings. In 2006, Clifton “Lite” Lee brought heroin from markets in New Jersey and New York to Roanoke, where he connected with users across racial lines. Two suburban teenagers caught selling for him had been supplying friends; information on their cellphones implicated fifty other young people, many of them students at Hidden Valley High School. By the time Lee was sentenced in 2008, prosecutors had attributed to his network the delivery of a thousand bags of heroin to the region two or three times a week. The episode shows how illicit distribution could convert a broader market into a local network of users and intermediaries.

Economic conditions and unequal access to care

The book places supply expansion alongside the collapse of work, rising disability, and insecurity in rural communities, without treating economic decline as a substitute explanation. In Martinsville and Henry County in Virginia, unemployment rose above 20 percent, food-stamp claims more than tripled, and disability rates increased by 60.4 percent. The account presents these conditions as part of the ground on which widespread opioid exposure became especially destructive: economic disruption could deepen distress, while expanded access to painkillers supplied a means of harm.

Treatment access was another part of the landscape. Virginia repeatedly declined Medicaid expansion after passage of the Affordable Care Act, forgoing $6.6 million in federal funds per day and coverage for 400,000 low-income residents. In states that expanded Medicaid, the program helped pay for treatment, counseling, and addiction medication, including for people who were too poor to afford private insurance but did not qualify for Medicaid under earlier rules. In Virginia, a teacher without insurance for decades relied on free services from Remote Area Medical and visits from the Health Wagon; she delayed seeing her family doctor, who charged $63 per visit at a discounted cash rate. The example shows how limited coverage could leave people with few practical routes to care.

Community, recovery, and the limits of availability

The argument about supply does not end with the amount of medication prescribed or the availability of illicit drugs. The book also emphasizes what can help people build lives apart from drugs: work, recreation, and sustaining relationships. A historian of the U.S. Narcotics Farms argues that these alternate sources of reward are essential and that communities must be rebuilt if the current configuration of drug use is to recede. In this account, recovery depends not only on controlling supply but also on creating meaningful alternatives and accessible support.

The gaps between health care and criminal justice further complicate that task. Families and volunteers worked to keep people alive while addicted people tried to avoid withdrawal, often in a system whose institutions were disconnected or at odds. Even where Medication-assisted treatment was officially accepted, some Narcotics Anonymous members declined to sponsor a woman taking buprenorphine because they viewed it as incompatible with being drug-free. Such rejection could make an already narrow path to support harder to follow. Supply expansion explains how exposure spread; the book’s wider analysis shows why the effects could persist when treatment, social support, and economic security remained unevenly available.